Showing results (371-380 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 27, 2021
Eosinophilic Vasculitis and Arteritic Anterior Ischemic Optic Neuropathy Associated With Anti-PD-L1 TherapyElla C Berry, Sean Mullany, Alannah Quinlivan, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 18, 2022
Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter StudyNatasja Hendriks, Margot M Koeneman, Anna J M van de Sande, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 16, 2019
Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United StatesWaqar Haque, Vivek Verma, Edward Brian Butler, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 16, 2019
Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit SurveyCandice Lesage, Christine Longvert, Sorilla Prey, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 31, 2019
A Brief Communication on Circulating PD-1-positive T-Regulatory Lymphocytes in Melanoma Patients Undergoing Adjuvant Immunotherapy With NivolumabThilo Gambichler, Ulrike Schröter, Stefan Höxtermann, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 31, 2019
Preferential Homing of Tumor-specific and Functional CD8+ Stem Cell-like Memory T Cells to the Bone MarrowKang Wu, Yongchao Li, Shaoying Zhang, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 28, 2022
B2M and JAK1/2-mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 TherapyChenzhi Zhang, Dandan Li, Binyi Xiao, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 2, 2018
The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell-mediated Antitumor Immune Response Through Activation of Antigen-presenting CellsChristian Merz, Jaromir Sykora, Viola Marschall, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2018
Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic MelanomaFlorentia Dimitriou, Alexandra V Matter, Joanna Mangana, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 2, 2019
PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate CancerRoberto Iacovelli, Chiara Ciccarese, Matteo Brunelli, et al.Pageof 175